← Back to WP3 Peptides & Research Index
Neutral technical overview for qualified laboratories. Not medical advice or promotional content.
Summary: Synthetic pentadecapeptide (sequence derived from gastric protein) examined in preclinical models for tissue protection, angiogenesis, and inflammatory modulation.
For Research Use Only. Not for human or veterinary consumption, diagnosis, treatment, or any therapeutic application. Institutional oversight, appropriate PPE, and compliance with local regulations are required.
Research Context
- Explored in rodent and in vitro models involving tendon, ligament, and GI injury environments.
- Evaluated for effects on angiogenesis, microcirculation, and inflammatory markers in controlled systems.
- Data remain preclinical; no major medicines regulator has approved BPC-157 as a drug product.
Handling, Quality & Stability
- Verify identity and purity via vendor COA (e.g., HPLC/MS) before use.
- Store lyophilized material frozen, protected from light and moisture per internal SOP.
- Aliquot on first open to avoid repeated freeze–thaw; label with lot, concentration, and expiry.
- Use appropriate PPE and engineering controls consistent with local chemical safety programs.
Documentation & Traceability Checklist
- COA including methods, impurity profile, and specification limits.
- Documented lot numbers, supplier details, and chain-of-custody from receipt to use.
- Storage and temperature logs for freezers/fridges containing this material.
- Aliquot and usage logs mapping experiment IDs, dates, and responsible personnel.
Regulatory & Compliance Notes
- Not approved as a therapeutic drug product; status varies by jurisdiction.
- Must not be labeled, marketed, or used as a finished pharmaceutical or dietary supplement.
- For laboratory, non-clinical research settings operating under applicable institutional policies.
This content is provided for educational context only and does not supersede applicable laws, regulatory guidance, or your internal SOPs.